Dados B3 › CSAN3
CSAN3 (Cosan): has profit grown?
CSAN3 (Cosan): in 2025, net loss was R$ 9.7 billion, a loss in both years versus 2024 (a loss of R$ 9.4 billion); five years earlier (2020), a profit of R$ 851.9 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | -R$ 9.7 billion | a loss in both years |
| 2024 | -R$ 9.4 billion | a turn from profit to loss |
| 2023 | R$ 1.1 billion | down 7% |
| 2022 | R$ 1.2 billion | down 81% |
| 2021 | R$ 6.1 billion | up 619% |
| 2020 | R$ 851.9 million | down 65% |
| 2019 | R$ 2.4 billion | up 47% |
| 2018 | R$ 1.7 billion | up 26% |
| 2017 | R$ 1.3 billion | up 27% |
| 2016 | R$ 1.0 billion | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/CSAN3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: CSAN3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:08 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:08 UTC. If this does not match /saude, you are reading a cached copy.